Hospital Mergers Under Pressure: The Remedies That Move Deals Forward
This Feature Article is brought to you by AHLA's Antitrust Practice Group.
- May 01, 2026
- Amanda Wait , Michael Best & Friedrich LLP
Health care dealmakers often spend months crafting the perfect transaction—negotiating specific terms, mapping operational synergies, and aligning incentives—only to encounter an unexpected friction point: federal or state merger review. When a deal has been precisely calibrated, parties are understandably reluctant to make alterations to satisfy antitrust enforcers. Yet, in the health care sector in which consolidation draws intense scrutiny, the question seldom is whether antitrust review will come, but rather how lengthy or burdensome will the inquiry be, and what form of remedy, if any, will be required to secure clearance?
ARTICLE TAGS
You must be logged in to access this content.